These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27979553)

  • 1. Re: Oral Enclomiphene Citrate Raises Testosterone and Preserves Sperm Counts in Obese Hypogonadal Men, Unlike Topical Testosterone: Restoration Instead of Replacement.
    Niederberger C
    J Urol; 2017 Jan; 197(1):233. PubMed ID: 27979553
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.
    Kim ED; McCullough A; Kaminetsky J
    BJU Int; 2016 Apr; 117(4):677-85. PubMed ID: 26496621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel.
    Kaminetsky J; Werner M; Fontenot G; Wiehle RD
    J Sex Med; 2013 Jun; 10(6):1628-35. PubMed ID: 23530575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.
    Wiehle RD; Fontenot GK; Wike J; Hsu K; Nydell J; Lipshultz L;
    Fertil Steril; 2014 Sep; 102(3):720-7. PubMed ID: 25044085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enclomiphene citrate for the treatment of secondary male hypogonadism.
    Rodriguez KM; Pastuszak AW; Lipshultz LI
    Expert Opin Pharmacother; 2016 Aug; 17(11):1561-7. PubMed ID: 27337642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive endocrinology: Oral enclomiphene citrate in obese men with hypogonadism.
    Kovac JR
    Nat Rev Urol; 2016 Mar; 13(3):133-4. PubMed ID: 26787395
    [No Abstract]   [Full Text] [Related]  

  • 7. Are SERMs safe and effective for the treatment of hypogonadism in men?
    Joseph T; Gibbs LM; Pham K
    J Fam Pract; 2022 Jan; 71(1):E18-E21. PubMed ID: 35259334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men.
    Hill S; Arutchelvam V; Quinton R
    IDrugs; 2009 Feb; 12(2):109-19. PubMed ID: 19204885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism.
    Earl JA; Kim ED
    Expert Rev Endocrinol Metab; 2019 May; 14(3):157-165. PubMed ID: 31063005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.
    Niederberger C
    J Urol; 2015 Jun; 193(6):2053-4. PubMed ID: 25986825
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment.
    Helo S; Mahon J; Ellen J; Wiehle R; Fontenot G; Hsu K; Feustel P; Welliver C; McCullough A
    BJU Int; 2017 Jan; 119(1):171-176. PubMed ID: 27511863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of isomers of clomiphene citrate on reproductive tissues in male mice.
    Fontenot GK; Wiehle RD; Podolski JS
    BJU Int; 2016 Feb; 117(2):344-50. PubMed ID: 26220499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics.
    Macdonald AA; Stewart AW; Farquhar CM
    Hum Reprod; 2013 Dec; 28(12):3178-87. PubMed ID: 24129611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency.
    Kaminetsky J; Hemani ML
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1947-55. PubMed ID: 19938905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is high dosage testosterone an effective male contraceptive agent?
    Matsumoto AM
    Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
    Saad F; Yassin A; Doros G; Haider A
    Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
    Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy.
    Kohn TP; Louis MR; Pickett SM; Lindgren MC; Kohn JR; Pastuszak AW; Lipshultz LI
    Fertil Steril; 2017 Feb; 107(2):351-357.e1. PubMed ID: 27855957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.